Skip to main content
Swedish Orphan Biovitrum AB (publ) (STO: SOBI)
Sweden flag Sweden · Delayed Price · Currency is SEK
302.00
+1.80 (0.60%)
Nov 19, 2024, 5:29 PM CET

SOBI Revenue

Swedish Orphan Biovitrum AB had revenue of 6.89B SEK in the quarter ending September 30, 2024, with 33.40% growth. This brings the company's revenue in the last twelve months to 25.44B, up 19.58% year-over-year. In the year 2023, Swedish Orphan Biovitrum AB had annual revenue of 22.12B with 17.74% growth.

Revenue (ttm)
25.44B
Revenue Growth
+19.58%
P/S Ratio
4.06
Revenue / Employee
14.02M
Employees
1,772
Market Cap
103.10B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202322.12B3.33B17.74%
Dec 31, 202218.79B3.26B21.00%
Dec 31, 202115.53B268.00M1.76%
Dec 31, 202015.26B1.01B7.11%
Dec 31, 201914.25B5.11B55.90%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca PLC 519.35B
Sectra AB (publ) 3.17B
Getinge AB (publ) 33.59B
Camurus AB (publ) 1.69B
Vitrolife AB (publ) 3.56B
Medicover AB (publ) 22.60B
Elekta AB (publ) 18.12B
Bonesupport Holding AB (publ) 814.46M
Revenue Rankings

Swedish Orphan Biovitrum AB News

More News